Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Post by newinvestor2019on Oct 21, 2018 9:08am
186 Views
Post# 28842841

aurora

aurora
30. ICC Labs Inc.: 100% ownership; $1.95 per share (payable in common shares of Aurora) $290 million CAD $220USD; projected 450,000 kg of production; 26,638 consumers were registered with ICC Labs as of June 2018;
- Columbia licenses (50 million people): ICC Labs’ Colombian subsidiary a license to cultivate psychoactive cannabis plants for medicinal purposes for domestic and international distribution; 124,000 sq. ft. greenhouse
- ICC Labs, Inc. owns 25% of in Global Group Kalapa S.L. (“KALAPA”), a private company headquartered in Barcelona Spain with the option to acquire the remaining 75% through the end of 2018. KALAPA is the first pan-European medical consultancy specializing in treatments with cannabinoids - as owning 100% of KSK Labs, a producer and manufacturer of products based on CBD with a presale agreement with Spain based VenPharma for an initial 140,000 CBD products with the next order to be 370,000 CBD annually to be sold via 1,300 points of sale;
- Only Uruguay publicly traded license producer; there is one other but it is a private company; licensed 550 acres for hemp CBD production and export; currently 69 acres of hemp production as of April 2018; GMP certified extraction lab in Uruguay; Domestic cannabis rec market 3.1 million people with two licensed producers;
- ICC has deal to export CBD to Emblem; presale of 10% of ICC's CBD production in 2018
- Deal with Nuuvera now part of Aphria to export CBDs oils/crystals; ICC subsidiary Tersum S.A., will export 150 kilograms CBD crystal in 2018 to ARA - Avanti Rx Analytics Inc., a subsidiary of Nuuvera Inc.;
- ICC has deal with CanPharma to export to Germany CBD isolate, oils and other derivatives, as well as various medicinal tetrahydrocannabinol (THC) cannabis products, including dried flowers and cannabis extracts from facilities in Uruguay and Colombia. The export arrangement for (THC) cannabis products is subject to receipt of the requisite regulatory approvals and the negotiation of definitive agreements by the end of second quarter in 2018;
- ICC has presale agreement to Mexico pharmacies 120,000 30 milliliter CBD oil bottles; Presale agreement with pharmaceutical chain in Brazil 180,000 30 milliliter of CBD oil bottles; Brazil/Mexico CBD bottles cost to produce $0.10 gram dry flower; 30 milliliter retail value of $40 USD to $200 USD estimated on international market (Midas Letter interview);
31. Agropro UAB: 100% ownership: Europe's biggest producer, processor and supplier of hemp and Borela UAB: 100% ownership: Hemp processor and distributor for 5.36 million euros, or $6.2 million, in cash; 1,600 hectares under contract that can potentially yield more than 1 million kg of organic hemp with the possibility of adding more than 3,000 hectares across the Baltic Republics and Poland
32. Supply Agreements in Canada:
a. Ontario: KG TBD
b. Shoppers Drugmart; Canada’s largest pharmacy retailer
c. Alberta: Aurora to allocate up to 25,000 kg of product for the first 6 months of sales
d. Alberta: via MedReleaf terms not disclosed but possibly 25,000 kg
e. British Columbia: Both Aurora and MedReleaf; terms not announced
f. Quebec: Aurora 5,000 kg; MedReleaf 8,000 kg
g. Emblem: presale of 10% of ICC's CBD production in 2018
h. Nuuvera now Aphria: 150 kilograms CBD crystal in 2018
i. Namaste Tech: TBD
j. Sundial: up to 250,000 grams of CBD crystal per year
k. Alcanna: TBD 37 retail stores in Alberta province to be increased as regulations allow
l. Yukon: TBD
m. Manitoba: TBD
n. Prince Edward Island: TBD
o. Newfoundland: TBD
p. Labrador: TBD
33. International Supply Agreements
a. Germany via ICC Labs: CanPharma GmbH, a licensed importer and wholesaler of narcotics TBD
b. Columbia via ICC Labs: Hlessing Industries presale of 42,000 grams of THC extract, 11,000
grams of CBD extract, 118,000 milliliters of THC oil and 30,000 milliliters of CBD oil
c. Mexico via ICC Labs; presale of 120,000 30 milliliter of CBD oil bottles
d. Brazil via ICC Labs; presale of 180,000 30 milliliter of CBD oil bottles
e. Spain via ICC Labs: 140,000 CBD products with intention next orders is to sell 370,000 CBD
products annually
f. Italy: via Pedanios TBD; have shipped previously
g. Germany: via 100% owned Pedanios distribution company; TBD

Bullboard Posts